Cleared Special

K202701 - GIA Stapler with Tri-Staple Technology

K202701 is the FDA 510(k) clearance for GIA Stapler with Tri-Staple Technology by Covidien. It is a Class 2 General & Plastic Surgery device (product code GDW) cleared through the Special 510(k) pathway after a 82-day FDA review.

K202701 · Covidien · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2020
Decision
82d
Days
Class 2
Risk

K202701 is an FDA 510(k) clearance for the GIA Stapler with Tri-Staple Technology. Classified as Staple, Implantable (product code GDW), Class II - Special Controls.

Submitted by Covidien (Min Hang District, Shanghai, CN). The FDA issued a Cleared decision on December 7, 2020 after a review of 82 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4750 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Covidien devices

Submission Details

510(k) Number K202701 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 2020
Decision Date December 07, 2020
Days to Decision 82 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d faster than avg
Panel avg: 115d · This submission: 82d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code GDW Staple, Implantable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GDW Staple, Implantable

All 157
Devices cleared under the same product code (GDW) and FDA review panel - the closest regulatory comparables to K202701.
EEA Circular Stapler with Tri-Staple Technology
K202507 · Covidien · Jan 2021
TissueTak device
K203117 · Via Surgical , Ltd. · Jan 2021
Disposable Powered Articulating Endoscopic Linear Cutter Stapler & Reloads
K202467 · Fengh Medical Co., Ltd. · Dec 2020
Tri-Staple 2.0 Reloads
K202864 · Covidien · Oct 2020
Echelon Flex 45mm Powered Plus Articulating Endoscopic Linear cutters, Echelon Flex 60mm Powered Plus Articulating Endoscopic Linear cutters, Echelon Endopath Endoscopic Linear Cutter Reloads, 45mm, Echelon Endopath Endoscopic Linear Cutter Reloads, 60mm
K202665 · Ethicon Endo-Surgery, LLC · Oct 2020
AEON Endoscopic Stapler
K201882 · Lexington Medical, Inc. · Oct 2020